Hear from some of the greatest minds in science on a range of topics in conversation with editors from Science custom publishing.
Science Custom Publishing
Claim This Podcastby Science Custom Publishing
5.0(1 reviews)
2 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Hear from some of the greatest minds in science on a range of topics in conversation with editors from Science custom publishing.
Language
🇺🇲
Publishing Since
12/11/2024
1 verified contact email on file for Science Custom Publishing
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
September 4, 2025
AI meets medicine: How academic–industry alliances are accelerating drug discovery
Senior Editor Erika Berg interviews AstraZeneca's Jim Weatherall and Stanford's Russ Altman on how AI and academic-industry alliances accelerate drug discovery and deliver life-saving therapies.
December 11, 2024
Investing in cell therapy for solid tumors
Progress in the development of cell therapies for the treatment of a range of diseases is accelerating, helped along by advancements in gene editing and manufacturing techniques. Pharmaceutical company AstraZeneca has been investing heavily in cell therapy technologies for the treatment of cancer, particularly solid tumors that pose distinct challenges, and is looking to make contributions to patient care. In this podcast from the Science custom publishing office and funded by Astrazeneca, Senior Editor Erika Berg interviews Mark Cobbold, Senior Vice President of Discovery and the Head of Oncology Cell Therapy at AstraZeneca. They explore the future of cell therapy in cancer treatment, the science behind "living medicines," and the vision of scalable, off-the-shelf cell therapies. This episode is a must-listen for anyone passionate about the future of oncology and personalized medicine.
2 total episodes available
Recent guests on Science Custom Publishing
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jim Weatherall
Guest
Russ Altman
Guest
Deep-dive analytics for Science Custom Publishing
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Science Custom Publishing?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.